Robert Damitz

Director, Formulation Development @Kriya Therapeutics, Inc.

Raleigh-Durham-Chapel Hill, NC, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Oct 2023 — Present

Director, Formulation Development @Kriya Therapeutics, Inc.

View department →

Raleigh-Durham-Chapel Hill, NC, US

Built high-performing formulation development group at gene therapy startup. Hired and trained top talent. Implemented novel analytical techniques to improve product stability. Planned and managed budgets and development timelines to meet company goals and objectives. Owned formulation, drug product, and administration device topics on CMC teams advancing numerous assets from candidate selection to IND/CTA & FPI readiness. Developed & implemented systematic formulation development approach to identify highly stable formulations for multiple viral vector (AAV) serotypes. Supported stability-indicating analytical method assessments by designing and executing robust forced degradation studies. Established in-use stability for all pipeline candidates while optimizing clinical and commercial product presentations. Published findings at top cell & gene therapy conferences with numerous submissions selected for oral presentations.

EDUCATION

N/A

University of Florida

Ph.D., Chemical Engineering

N/A

University of Michigan

B.S. Engineering, Chemical Engineering

SKILLS

Technical CommunicationLiposomesData AnalysisPharmaceuticsProgrammingLight ScatteringPharmacokineticsProject ManagementGuitarTechnical LeadershipPk/PdAnalytical ChemistryMathematical ModelingAseptic TechniqueMatlabResearch Project ManagementBacterial Cell CultureProcess EngineeringResearch and Development (R&D)CelloRegulatory SubmissionsEmulsionsNmr SpectroscopyPreformulationDissolutionUv/VisGc-MsChromatographyPythonEngineeringCgmpResearchFormulationChemical EngineeringColloidsDrug DeliveryStatistical Data AnalysisAdmeHuman PhysiologyDesign of Experiments

ABOUT ROBERT DAMITZ

I am passionate about improving patients\' lives & addressing unmet medical needs with groundbreaking pharmaceutical therapies. I am an enthusiastic and versatile scientific leader offering a holistic focus on product quality and patient safety to CMC development. I have diverse formulation and process development experience from roles in cell & gene therapy and small molecule specialty dosage forms. I am well-versed in analytical techniques, regulatory environments and cGMPs. I have held roles as both the CMO and the client, and I value good working relationships between parties. I have excellent technical communication skills and am adept at condensing complex topics to be easily understood. I enjoy mentoring, educating, and building teams for success.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.